Thomas Schlueter is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Senior Director of R&D Program Management at BioNTech SE since November 2023. Previously, Schlueter held roles at Affimed, where notable contributions included leadership as Sr. Program Director on the AFM13 project, an innovative therapeutic targeting CD30-positive hematologic tumors. Prior to Affimed, Schlueter worked as Program Director at Novaliq GmbH, overseeing key Phase 2/3 programs and preclinical projects for ocular therapeutics. Schlueter's extensive experience includes leadership roles at Phenex Pharmaceuticals AG, LION bioscience, and the Helmholtz-Zentrum für Infektionsforschung, complemented by a robust educational background with a degree in biology from Technische Universität Braunschweig.
This person is not in the org chart
This person is not in any teams
This person is not in any offices